Home›Trial›NCT06448793
🔬NCT06448793RECRUITING

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Study Summary

The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting

Conditions
Non-small Cell Lung Cancer (NSCLC)
Interventions / Drugs
Approved Non-small Cell Lung Cancer (NSCLC) therapies
View on ClinicalTrials.gov ↗
Sponsor
BMY
Bristol-Myers Squibb
Oncology
F35/100
Study Details
Enrollment55 participants
Primary Completion—
Lead SponsorBristol-Myers Squibb
Data Retrieved2026-04-11 04:08:14.746734+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.